Since USP1-mediated deubiquitination of KPNA2 contributes to tumorigenesis, researchers have found that inhibitors of USP1 such as pimozide and ML323 decrease breast cancer metastasis without showing obvious cytotoxicity in mice, offering a novel therapeutic target to be explored in the future [84]. This evidence concerns the gene USP1 and breast cancer.